11th February 2020
- 0 comments
Foresight has made a £500,000 growth capital investment into Novel Technologies Holding Limited, developers of antimicrobial technology SILVERbac. This is the third investment made by the £20 million Foresight Scottish Growth Fund which is financed by the Scottish Growth Scheme through a combination of Scottish Government funds and the European Regional Development Fund (ERDF), and is part of a wider £2.1 million funding round for NTH.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.